{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:50:34Z","timestamp":1780051834803,"version":"3.53.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24112"],"award-info":[{"award-number":["24112"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The strongest genetic risk factor of Beh\u00e7et\u2019s disease (BD) is <jats:italic>HLA-B*51<\/jats:italic>. Our group previously reported that <jats:italic>HLA-A*26<\/jats:italic> is independently associated with the risk of the onset of BD apart from <jats:italic>HLA-B*51<\/jats:italic>. Here, we re-evaluated the association between <jats:italic>HLA-A*26<\/jats:italic> and BD in the Japanese population. We also performed a comprehensive literature search and meta-analyzed the extracted published data concerning the relationship between <jats:italic>HLA-A*26<\/jats:italic> and BD to estimate the odds ratio (OR) of <jats:italic>HLA-A*26<\/jats:italic> to BD. In this study, we genotyped 611 Japanese BD patients and 2,955 unrelated ethnically matched healthy controls. Genotyping results showed that the phenotype frequency of <jats:italic>HLA-A*26<\/jats:italic> was higher in BD patients than in controls (OR\u2009=\u20092.12, 95%\u2009CI: 1.75\u20132.56). Furthermore, within the <jats:italic>HLA-B*51<\/jats:italic>-negative populations, the phenotype frequency of <jats:italic>HLA-A*26<\/jats:italic> was significantly higher in BD patients than in controls (OR\u2009=\u20093.10, 95%\u2009CI: 2.43\u20133.95). Results obtained from meta-analysis combined with our data showed that the modified OR of <jats:italic>HLA-A*26<\/jats:italic> became 1.80 (95%\u2009CI:1.58\u20132.06), whereas within the <jats:italic>HLA-B*51<\/jats:italic>-negative population, the modified OR became 4.02 (95%\u2009CI: 2.29\u20137.05). A subgroup analysis arranged by the geographical regions showed <jats:italic>HLA-A*26<\/jats:italic> is in fact associated with the onset of BD in Northeast Asia (OR\u2009=\u20092.11, 95%\u2009CI: 1.75\u20132.56), but not in the Middle East or in Europe.<\/jats:p>","DOI":"10.1038\/s41598-019-40824-y","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T12:06:06Z","timestamp":1552565166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The association analysis between HLA-A*26 and Beh\u00e7et\u2019s disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Jutaro","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Meguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Mizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsukata","family":"Kawagoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Mizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"40824_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/nejm199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane, T., Takeno, M., Suzuki, N. & Inaba, G. Behcet\u2019s disease. The New England journal of medicine 341, 1284\u20131291, https:\/\/doi.org\/10.1056\/nejm199910213411707 (1999).","journal-title":"The New England journal of medicine"},{"key":"40824_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","volume":"27","author":"VG Kaklamani","year":"1998","unstructured":"Kaklamani, V. G., Vaiopoulos, G. & Kaklamanis, P. G. Behcet\u2019s Disease. Seminars in arthritis and rheumatism 27, 197\u2013217 (1998).","journal-title":"Seminars in arthritis and rheumatism"},{"key":"40824_CR3","doi-asserted-by":"publisher","unstructured":"de Menthon, M., Lavalley, M. P., Maldini, C., Guillevin, L. & Mahr, A. HLA\u2013B51\/B5 and the Risk of Beh\u00e7et\u2019s Disease: A Systematic Review and Meta-Analysis of Case\u2013Control Genetic Association Studies. Arthritis and rheumatism 61, https:\/\/doi.org\/10.1002\/art.24642 (2009).","DOI":"10.1002\/art.24642"},{"key":"40824_CR4","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/ar3292","volume":"13","author":"EH Kang","year":"2011","unstructured":"Kang, E. H. et al. Associations between the HLA-A polymorphism and the clinical manifestations of Behcet\u2019s disease. Arthritis research & therapy 13, R49, https:\/\/doi.org\/10.1186\/ar3292 (2011).","journal-title":"Arthritis research & therapy"},{"key":"40824_CR5","doi-asserted-by":"publisher","unstructured":"Kuranov, A. B. et al. Behcet\u2019s disease in HLA-B*51 negative Germans and Turks shows association with HLA-Bw4-80I. Arthritis research & therapy 16, https:\/\/doi.org\/10.1186\/ar4569 (2014).","DOI":"10.1186\/ar4569"},{"key":"40824_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4137\/CMAMD.S39879","volume":"9","author":"F Al-Okaily","year":"2016","unstructured":"Al-Okaily, F. et al. Genetic association of HLA-A*26,-A*31, and-B*51 with Behcet\u2019s disease in Saudi patients. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 9, 167\u2013173, https:\/\/doi.org\/10.4137\/CMAMD.S39879 (2016).","journal-title":"Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders"},{"key":"40824_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1399-0039.1997.tb02835.x","volume":"50","author":"N Mizuki","year":"1997","unstructured":"Mizuki, N. et al. A strong association between HLA-B*5101 and Behcet\u2019s disease in Greek patients. Tissue antigens 50, 57\u201360 (1997).","journal-title":"Tissue antigens"},{"key":"40824_CR8","first-page":"S39","volume":"28","author":"T Kaburaki","year":"2010","unstructured":"Kaburaki, T. et al. Genetic association of HLA-A*2601 with ocular Behcet\u2019s disease in Japanese patients. Clin Exp Rheumatol 28, S39\u201344 (2010).","journal-title":"Clin Exp Rheumatol"},{"key":"40824_CR9","first-page":"29","volume":"23","author":"A Kurumi","year":"2011","unstructured":"Kurumi, A. Asociation of HLA-A26 with Behc\u0327et\u2019s Disease in Japanese patients. Clinical rheumatology 23, 29\u201336 (2011).","journal-title":"Clinical rheumatology"},{"key":"40824_CR10","first-page":"413","volume":"89","author":"YM Chung","year":"1990","unstructured":"Chung, Y. M. et al. Behcet\u2019s disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. Journal of the Formosan Medical Association\u2009=\u2009Taiwan yi zhi 89, 413\u2013417 (1990).","journal-title":"Journal of the Formosan Medical Association\u2009=\u2009Taiwan yi zhi"},{"key":"40824_CR11","doi-asserted-by":"publisher","unstructured":"Elfishawi, M. M. et al. HLA Class I in Egyptian patients with Beh\u00e7et\u2019s disease: new association with susceptibility, protection, presentation and severity of manifestations. Immunological investigations, 1\u20139, https:\/\/doi.org\/10.1080\/08820139.2018.1517364 (2018).","DOI":"10.1080\/08820139.2018.1517364"},{"key":"40824_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/ard.2009.108571","volume":"69","author":"A Meguro","year":"2010","unstructured":"Meguro, A. et al. Genetics of Behcet disease inside and outside the MHC. Ann Rheum Dis 69, 747\u2013754, https:\/\/doi.org\/10.1136\/ard.2009.108571 (2010).","journal-title":"Ann Rheum Dis"},{"key":"40824_CR13","doi-asserted-by":"publisher","unstructured":"Middleton, D., Menchaca, L., Rood, H. & Komerofsky, R. New allele frequency database: http:\/\/www.allelefrequencies.net. Tissue antigens 61, 403\u2013407, https:\/\/doi.org\/10.1034\/j.1399-0039.2003.00062.x (2003).","DOI":"10.1034\/j.1399-0039.2003.00062.x"},{"key":"40824_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","volume":"42","author":"G Azizlerli","year":"2003","unstructured":"Azizlerli, G. et al. Prevalence of Behcet\u2019s disease in Istanbul, Turkey. International journal of dermatology 42, 803\u2013806 (2003).","journal-title":"International journal of dermatology"},{"key":"40824_CR15","first-page":"S53","volume":"22","author":"N Cakir","year":"2004","unstructured":"Cakir, N. et al. Prevalence of Behcet\u2019s disease in rural western Turkey: a preliminary report. Clinical and experimental rheumatology 22, S53\u201355 (2004).","journal-title":"Clinical and experimental rheumatology"},{"key":"40824_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1076\/opep.9.5.325.10338","volume":"9","author":"A Idil","year":"2002","unstructured":"Idil, A. et al. The prevalence of Behcet\u2019s disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic epidemiology 9, 325\u2013331 (2002).","journal-title":"Ophthalmic epidemiology"},{"key":"40824_CR17","first-page":"820","volume":"15","author":"S Yurdakul","year":"1988","unstructured":"Yurdakul, S. et al. The prevalence of Behcet\u2019s syndrome in a rural area in northern Turkey. The Journal of rheumatology 15, 820\u2013822 (1988).","journal-title":"The Journal of rheumatology"},{"key":"40824_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/rheumatology\/keq331","volume":"50","author":"M Piga","year":"2011","unstructured":"Piga, M. & Mathieu, A. Genetic susceptibility to Behcet\u2019s disease: role of genes belonging to the MHC region. Rheumatology (Oxford, England) 50, 299\u2013310, https:\/\/doi.org\/10.1093\/rheumatology\/keq331 (2011).","journal-title":"Rheumatology (Oxford, England)"},{"key":"40824_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1399-0039.2004.00280.x","volume":"64","author":"I Pirim","year":"2004","unstructured":"Pirim, I., Atasoy, M., Ikbal, M., Erdem, T. & Aliagaoglu, C. HLA class I and class II genotyping in patients with Behcet\u2019s disease: a regional study of eastern part of Turkey. Tissue antigens 64, 293\u2013297, https:\/\/doi.org\/10.1111\/j.1399-0039.2004.00280.x (2004).","journal-title":"Tissue antigens"},{"key":"40824_CR20","first-page":"S51","volume":"30","author":"M Piga","year":"2012","unstructured":"Piga, M. et al. Genetics of Behcet\u2019s disease in Sardinia: two distinct extended HLA haplotypes harbour the B*51 allele in the normal population and in patients. Clin Exp Rheumatol 30, S51\u201356 (2012).","journal-title":"Clin Exp Rheumatol"},{"key":"40824_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1034\/j.1399-0039.1999.540605.x","volume":"54","author":"J Kera","year":"1999","unstructured":"Kera, J. et al. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behcet\u2019s disease in Italian patients. Tissue antigens 54, 565\u2013571 (1999).","journal-title":"Tissue antigens"},{"key":"40824_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1034\/j.1399-0039.2001.057005457.x","volume":"57","author":"N Mizuki","year":"2001","unstructured":"Mizuki, N. et al. HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behcet\u2019s disease. Tissue antigens 57, 457\u2013462 (2001).","journal-title":"Tissue antigens"},{"key":"40824_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1034\/j.1399-0039.1999.540308.x","volume":"54","author":"K Yabuki","year":"1999","unstructured":"Yabuki, K. et al. HLA class I and II typing of the patients with Behcet\u2019s disease in Saudi Arabia. Tissue antigens 54, 273\u2013277 (1999).","journal-title":"Tissue antigens"},{"key":"40824_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1034\/j.1399-0039.2002.590207.x","volume":"59","author":"N Mizuki","year":"2002","unstructured":"Mizuki, N. et al. Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behcet\u2019s disease in Greek patients. Tissue antigens 59, 118\u2013121 (2002).","journal-title":"Tissue antigens"},{"key":"40824_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard.50.6.351","volume":"50","author":"N Arber","year":"1991","unstructured":"Arber, N., Klein, T., Meiner, Z., Pras, E. & Weinberger, A. Close association of HLA-B51 and B52 in Israeli patients with Behcet\u2019s syndrome. Ann Rheum Dis 50, 351\u2013353 (1991).","journal-title":"Ann Rheum Dis"},{"key":"40824_CR26","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1073\/pnas.1406575111","volume":"111","author":"MJ Ombrello","year":"2014","unstructured":"Ombrello, M. J. et al. Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc Natl Acad Sci USA 111, 8867\u20138872, https:\/\/doi.org\/10.1073\/pnas.1406575111 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"40824_CR27","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1186\/ar4328","volume":"15","author":"MA Montes-Cano","year":"2013","unstructured":"Montes-Cano, M. A. et al. HLA and non-HLA genes in Behcet\u2019s disease: a multicentric study in the Spanish population. Arthritis research & therapy 15, R145, https:\/\/doi.org\/10.1186\/ar4328 (2013).","journal-title":"Arthritis research & therapy"},{"key":"40824_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1399-0039.2007.00907.x","volume":"70","author":"J Seo","year":"2007","unstructured":"Seo, J. et al. Association of CD94\/NKG2A, CD94\/NKG2C, and its ligand HLA-E polymorphisms with Behcet\u2019s disease. Tissue antigens 70, 307\u2013313, https:\/\/doi.org\/10.1111\/j.1399-0039.2007.00907.x (2007).","journal-title":"Tissue antigens"},{"key":"40824_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ng.2551","volume":"45","author":"T Hughes","year":"2013","unstructured":"Hughes, T. et al. Identification of multiple independent susceptibility loci in the HLA region in Behcet\u2019s disease. Nat Genet 45, 319\u2013324, https:\/\/doi.org\/10.1038\/ng.2551 (2013).","journal-title":"Nat Genet"},{"key":"40824_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-9-1","volume":"9","author":"J Sidney","year":"2008","unstructured":"Sidney, J., Peters, B., Frahm, N., Brander, C. & Sette, A. HLA class I supertypes: a revised and updated classification. BMC immunology 9, 1, https:\/\/doi.org\/10.1186\/1471-2172-9-1 (2008).","journal-title":"BMC immunology"},{"key":"40824_CR31","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.4049\/jimmunol.181.9.6293","volume":"181","author":"B Sanjanwala","year":"2008","unstructured":"Sanjanwala, B., Draghi, M., Norman, P. J., Guethlein, L. A. & Parham, P. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. Journal of immunology (Baltimore, Md.: 1950) 181, 6293\u20136300 (2008).","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"40824_CR32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/gene.2016.36","volume":"17","author":"B Erer","year":"2016","unstructured":"Erer, B. et al. Evaluation of KIR3DL1\/KIR3DS1 polymorphism in Behcet\u2019s disease. Genes and immunity 17, 396\u2013399, https:\/\/doi.org\/10.1038\/gene.2016.36 (2016).","journal-title":"Genes and immunity"},{"key":"40824_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000247340","volume":"186","author":"RE Brandsen","year":"1993","unstructured":"Brandsen, R. E. et al. SAPHO syndrome. Dermatology (Basel, Switzerland) 186, 176\u2013180, https:\/\/doi.org\/10.1159\/000247340 (1993).","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"40824_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10067-006-0349-4","volume":"26","author":"I Krause","year":"2007","unstructured":"Krause, I. et al. Prevalence and clinical aspects of Behcet\u2019s disease in the north of Israel. Clin Rheumatol 26, 555\u2013560, https:\/\/doi.org\/10.1007\/s10067-006-0349-4 (2007).","journal-title":"Clin Rheumatol"},{"key":"40824_CR35","doi-asserted-by":"publisher","unstructured":"Abi-Rached, L. et al. The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans. Science (New York, N.Y.), https:\/\/doi.org\/10.1126\/science.1209202 (2011).","DOI":"10.1126\/science.1209202"},{"key":"40824_CR36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1126\/science.1188021","volume":"328","author":"RE Green","year":"2010","unstructured":"Green, R. E. et al. A draft sequence of the Neandertal genome. Science (New York, N.Y.) 328, 710\u2013722, https:\/\/doi.org\/10.1126\/science.1188021 (2010).","journal-title":"Science (New York, N.Y.)"},{"key":"40824_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/tan.12852","volume":"88","author":"E Ashouri","year":"2016","unstructured":"Ashouri, E. et al. HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands. HLA 88, 87\u201399, https:\/\/doi.org\/10.1111\/tan.12852 (2016).","journal-title":"HLA"},{"key":"40824_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(00)02491-0","volume":"356","author":"PN Le Souef","year":"2000","unstructured":"Le Souef, P. N., Goldblatt, J. & Lynch, N. R. Evolutionary adaptation of inflammatory immune responses in human beings. Lancet 356, 242\u2013244 (2000).","journal-title":"Lancet"},{"key":"40824_CR39","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.705","volume":"42","author":"G Morelli","year":"2010","unstructured":"Morelli, G. et al. Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet 42, 1140\u20131143, https:\/\/doi.org\/10.1038\/ng.705 (2010).","journal-title":"Nat Genet"},{"key":"40824_CR40","first-page":"S123","volume":"32","author":"M Piga","year":"2014","unstructured":"Piga, M. & Mathieu, A. The origin of Behcet\u2019s disease geoepidemiology: possible role of a dual microbial-driven genetic selection. Clinical and experimental rheumatology 32, S123\u2013129 (2014).","journal-title":"Clinical and experimental rheumatology"},{"key":"40824_CR41","first-page":"59","volume":"10","author":"Y Mizushima","year":"1988","unstructured":"Mizushima, Y. Recent research into Behcet\u2019s disease in Japan. International journal of tissue reactions 10, 59\u201365 (1988).","journal-title":"International journal of tissue reactions"},{"key":"40824_CR42","unstructured":"SNP2HLA. Imputation of Amino Acid Polymorphisms in Human Leukocyte Antigens. http:\/\/software.broadinstitute.org\/mpg\/snp2hla\/."},{"key":"40824_CR43","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.1093\/hmg\/ddu387","volume":"23","author":"Y Okada","year":"2014","unstructured":"Okada, Y. et al. Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum Mol Genet 23, 6916\u20136926, https:\/\/doi.org\/10.1093\/hmg\/ddu387 (2014).","journal-title":"Hum Mol Genet"},{"key":"40824_CR44","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer, L. et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (Clinical research ed.) 350, g7647, https:\/\/doi.org\/10.1136\/bmj.g7647 (2015).","journal-title":"BMJ (Clinical research ed.)"},{"key":"40824_CR45","unstructured":"Wells, G. A. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40824-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40824-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40824-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T07:36:21Z","timestamp":1671262581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40824-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["40824"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-40824-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,14]]},"assertion":[{"value":"4 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4426"}}